(Press-News.org) In many neurodegenerative diseases the neurons of the brain are over-stimulated and this leads to their destruction. After many failed attempts and much scepticism this process was finally shown last year to be a possible basis for treatment in some patients with stroke. But very few targets for drugs to block this process are known.
In a new highly detailed study, researchers have discovered a previously missing link between over-stimulation and destruction of brain tissue, and shown that this might be a target for future drugs. This research, led by the A. I. Virtanen Institute at the University of Eastern Finland in collaboration with scientists from Lausanne University Hospital, University of Lausanne and the company Xigen Pharma AG, was published in the Journal of Neuroscience.
What is this missing link? We have known for years that over-stimulated neurons produce nitric oxide molecules. Although this can activate a signal for destruction of cells, the small amount of nitric oxide produced cannot alone explain the damage to the brain. The team now show that a protein called NOS1AP links the nitric oxide that is produced to the damage that results. NOS1AP binds an initiator of cell destruction called MKK3 and also moves within the cell to the source of nitric oxide when cells are over-activated. The location of these proteins in cells causes them to convert the over-stimulation signal into a cell destruction response. The team designed a chemical that prevents NOS1AP from binding the source of nitric oxide. This reduces the cell destruction response in cells of the brain and as a result it limits brain lesions in rodents.
This translational research was funded mainly by the Academy of Finland, the European Union and the University of Eastern Finland and used the recently developed high-throughput imaging facilities at the A. I. Virtanen Institute. The researchers hope that continuation of their work could lead to improved treatments for diseases such as stroke, epilepsy and chronic conditions like Alzheimer's disease. As NOS1AP is associated with schizophrenia, diabetes and sudden cardiac death, future research in this area may assist the treatment of a wider range of diseases.
###
For further information, please contact: Professor Michael Courtney, tel. +358 40 355 3663, mjczmjc@gmail.com.
http://www.uef.fi/fi/aivi/neuro/signalling-research
Li-Li Li, Vanessa Ginet, Xiaonan Liu, Olga Vergun, Minna Tuittila, Marc Mathieu, Christophe Bonny, Julien Puyal, Anita C. Truttmann, and Michael J. Courtney. The nNOS-p38MAPK Pathway Is Mediated by NOS1AP during Neuronal Death The Journal of Neuroscience, 8 May 2013, 33(19):8185-8201; doi:10.1523/JNEUROSCI.4578-12.2013.
http://www.jneurosci.org/content/33/19/8185.abstract
Researchers discover a missing link in signals contributing to neurodegeneration
2013-05-09
ELSE PRESS RELEASES FROM THIS DATE:
Early infant growth rate linked to composition of gut microbiota
2013-05-09
The composition of gut microbiota in a new-born baby's gut has been linked to the rate of early infant growth, reports research published this week in PLOS Computational Biology. The findings support the assertion that the early development of "microbiota" – the body's microbial ecosystem - in an infant can influence growth and thereby the likelihood of obesity.
The sterile gut of a new-born baby is quickly populated by a variety of different microbes. This study identified connections between different bacteria and both expected and reduced infant growth rates.
The ...
Patients should have right to control genomic health information
2013-05-09
Doctors should not have the right or responsibility to force-feed their patients with genomic information about their future health risks, according to bioethicists writing on May 9 in Trends in Biotechnology, a Cell Press publication. They write in response to controversial recommendations from the American College of Medical Genetics and Genomics (ACMG) on the reporting of incidental findings in clinical genome sequencing.
"A lot of people in this field would agree that no one has a right to withhold your health information from you," said Megan Allyse from the Stanford ...
Coral reefs suffering, but collapse not inevitable, researchers say
2013-05-09
Coral reefs are in decline, but their collapse can still be avoided with local and global action. That's according to findings reported in the Cell Press journal Current Biology on May 9 based on an analysis that combines the latest science on reef dynamics with the latest climate models.
"People benefit by reefs' having a complex structure—a little like a Manhattan skyline, but underwater," said Peter Mumby of The University of Queensland and University of Exeter. "Structurally complex reefs provide nooks and crannies for thousands of species and provide the habitat ...
Rejuvenating hormone found to reverse symptoms of heart failure
2013-05-09
Heart failure is one of the most debilitating conditions linked to old age, and there are no specific therapies for the most common form of this condition in the elderly. A study published by Cell Press May 9th in the journal Cell reveals that a blood hormone known as growth differentiation factor 11 (GDF11) declines with age, and old mice injected with this hormone experience a reversal in signs of cardiac aging. The findings shed light on the underlying causes of age-related heart failure and may offer a much-needed strategy for treating this condition in humans.
"There ...
Genes define the interaction of social amoeba and bacteria
2013-05-09
HOUSTON -- (May 9, 2013) – Amoeba eat bacteria and other human pathogens, engulfing and destroying them – or being destroyed by them, but how these single-cell organisms distinguish and respond successfully to different bacterial classes has been largely unexplained.
In a report in the journal Current Biology, researchers from Baylor College of Medicine use the model of the social amoeba – Dictyostelium discoideum – to identify the genetic controls on how the amoeba differentiate the different bacteria and respond to achieve their goal of destruction.
"No one has looked ...
Turning old hearts
2013-05-09
Cambridge, MA, May 9, 2013 - Two Harvard Stem Cell Institute researchers – one a stem cell biologist and one a practicing cardiologist at Brigham and Women's Hospital – have identified a protein in the blood of mice and humans that may prove to be the first effective treatment for the form of age-related heart failure that affects millions of Americans.
When the protein, called GDF-11, was injected into old mice, which develop thickened heart walls in a manner similar to aging humans, the hearts were reduced in size and thickness, resembling the healthy hearts of younger ...
Advance in tuberous sclerosis brain science
2013-05-09
PROVIDENCE, R.I. [Brown University] — Doctors often diagnose tuberous sclerosis complex (TSC) based on the abnormal growths the genetic disease causes in organs around the body. Those overt anatomical structures, however, belie the microscopic and mysterious neurological differences behind the disease's troublesome behavioral symptoms: autism, intellectual disabilities, and seizures. In a new study in mice, Brown University researchers highlight a role for a brain region called the thalamus and show that the timing of gene mutation during thalamus development makes a huge ...
Dad's genome more ready at fertilization than mom's is -- but hers catches up
2013-05-09
SALT LAKE CITY—Researchers from Huntsman Cancer Institute (HCI) at the University of Utah have discovered that while the genes provided by the father arrive at fertilization pre-programmed to the state needed by the embryo, the genes provided by the mother are in a different state and must be reprogrammed to match. The findings have important implications for both developmental biology and cancer biology.
In the earliest stages, embryo cells have the potential to develop into any type of cell, a state called totipotency. Later, this potency becomes restricted through ...
Gene identified, responsible for a spectrum of disorders affecting the bones and connective tissue
2013-05-09
Researchers from the RIKEN Center for Integrative Medical Sciences have identified a gene that when mutated is responsible for a spectrum of disorders affecting the bones and connective tissue. This finding opens new avenues for research into a diagnosis and treatment for these until now incurable diseases.
The study is published today in the American Journal of Human Genetics.
Spondyloepimetaphyseal dysplasia with joint laxity, type I or SEMD-JL1 is a disorder of the skeleton resulting in short stature and spinal problems starting from birth, and worsening with age. ...
Exit discovered in cellular garbage truck
2013-05-09
At the University of Geneva (UNIGE), the team led by Professor Jean Gruenberg has long been interested in the movement of lysosomes, the sub-compartments of cells to where endocytic vesicles deliver their waste content and the molecules destined to be destroyed. Within this context, researcher Christin Bissig, along with her international colleagues, carried out a detailed study of the route taken by Alix which is lodged inside the endosomal membrane. This tailing has highlighted how protein contributes to avoiding cellular digestion, like a door opening into the endosomal ...